The global market for Liver Cancer Treatment Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Liver Cancer Treatment Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Liver Cancer Treatment Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Liver Cancer Treatment Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Liver Cancer Treatment Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Liver Cancer Treatment Drug players cover 4SC AG, Alnylam Pharmaceuticals, Inc., AVEO Pharmaceuticals, Inc, Bayer AG and Becton, Dickinson and Co., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Liver Cancer Treatment Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Liver Cancer Treatment Drug market, with both quantitative and qualitative data, to help readers understand how the Liver Cancer Treatment Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Liver Cancer Treatment Drug market and forecasts the market size by Type (Targeted Therapy, Radiation Therapy and Immunotherapy), by Application (Hepatocellular Carcinoma, Cholangio Carcinoma, Hepatoblastoma and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Targeted Therapy
Radiation Therapy
Immunotherapy
Chemotherapy
Other
Segmentation by application
Hepatocellular Carcinoma
Cholangio Carcinoma
Hepatoblastoma
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
4SC AG
Alnylam Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc
Bayer AG
Becton, Dickinson and Co.
Bristol-Myers Squibb Co.
Celsion Corp.
Dicerna Pharmaceuticals, Inc.
Eli Lilly and Co.
Exelixis, Inc.
F. Hoffmann-La Roche, Ltd.
FibroGen, Inc.
General Electric Co.(GE Healthcare)
Merck & Co., Inc.(ArQule, Inc.)
Novartis International AG
Nymox Corp.
Pfizer, Inc.
SMC Laboratories, Inc.
Thermo Fisher Scientific, Inc.
Chapter Introduction
Chapter 1: Scope of Liver Cancer Treatment Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Liver Cancer Treatment Drug market size and CAGR, Liver Cancer Treatment Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Liver Cancer Treatment Drug revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Liver Cancer Treatment Drug revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Liver Cancer Treatment Drug market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including 4SC AG, Alnylam Pharmaceuticals, Inc., AVEO Pharmaceuticals, Inc, Bayer AG, Becton, Dickinson and Co., Bristol-Myers Squibb Co., Celsion Corp., Dicerna Pharmaceuticals, Inc. and Eli Lilly and Co., etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Liver Cancer Treatment Drug Market Size 2017-2028
2.1.2 Liver Cancer Treatment Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Liver Cancer Treatment Drug Segment by Type
2.2.1 Targeted Therapy
2.2.2 Radiation Therapy
2.2.3 Immunotherapy
2.2.4 Chemotherapy
2.2.5 Other
2.3 Liver Cancer Treatment Drug Market Size by Type
2.3.1 Liver Cancer Treatment Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Liver Cancer Treatment Drug Market Size Market Share by Type (2017-2022)
2.4 Liver Cancer Treatment Drug Segment by Application
2.4.1 Hepatocellular Carcinoma
2.4.2 Cholangio Carcinoma
2.4.3 Hepatoblastoma
2.4.4 Other
2.5 Liver Cancer Treatment Drug Market Size by Application
2.5.1 Liver Cancer Treatment Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Liver Cancer Treatment Drug Market Size Market Share by Application (2017-2022)
3 Liver Cancer Treatment Drug Market Size by Player
3.1 Liver Cancer Treatment Drug Market Size Market Share by Players
3.1.1 Global Liver Cancer Treatment Drug Revenue by Players (2020-2022)
3.1.2 Global Liver Cancer Treatment Drug Revenue Market Share by Players (2020-2022)
3.2 Global Liver Cancer Treatment Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Liver Cancer Treatment Drug by Regions
4.1 Liver Cancer Treatment Drug Market Size by Regions (2017-2022)
4.2 Americas Liver Cancer Treatment Drug Market Size Growth (2017-2022)
4.3 APAC Liver Cancer Treatment Drug Market Size Growth (2017-2022)
4.4 Europe Liver Cancer Treatment Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Liver Cancer Treatment Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Liver Cancer Treatment Drug Market Size by Country (2017-2022)
5.2 Americas Liver Cancer Treatment Drug Market Size by Type (2017-2022)
5.3 Americas Liver Cancer Treatment Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liver Cancer Treatment Drug Market Size by Region (2017-2022)
6.2 APAC Liver Cancer Treatment Drug Market Size by Type (2017-2022)
6.3 APAC Liver Cancer Treatment Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Liver Cancer Treatment Drug by Country (2017-2022)
7.2 Europe Liver Cancer Treatment Drug Market Size by Type (2017-2022)
7.3 Europe Liver Cancer Treatment Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Liver Cancer Treatment Drug by Region (2017-2022)
8.2 Middle East & Africa Liver Cancer Treatment Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Liver Cancer Treatment Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Liver Cancer Treatment Drug Market Forecast
10.1 Global Liver Cancer Treatment Drug Forecast by Regions (2023-2028)
10.1.1 Global Liver Cancer Treatment Drug Forecast by Regions (2023-2028)
10.1.2 Americas Liver Cancer Treatment Drug Forecast
10.1.3 APAC Liver Cancer Treatment Drug Forecast
10.1.4 Europe Liver Cancer Treatment Drug Forecast
10.1.5 Middle East & Africa Liver Cancer Treatment Drug Forecast
10.2 Americas Liver Cancer Treatment Drug Forecast by Country (2023-2028)
10.2.1 United States Liver Cancer Treatment Drug Market Forecast
10.2.2 Canada Liver Cancer Treatment Drug Market Forecast
10.2.3 Mexico Liver Cancer Treatment Drug Market Forecast
10.2.4 Brazil Liver Cancer Treatment Drug Market Forecast
10.3 APAC Liver Cancer Treatment Drug Forecast by Region (2023-2028)
10.3.1 China Liver Cancer Treatment Drug Market Forecast
10.3.2 Japan Liver Cancer Treatment Drug Market Forecast
10.3.3 Korea Liver Cancer Treatment Drug Market Forecast
10.3.4 Southeast Asia Liver Cancer Treatment Drug Market Forecast
10.3.5 India Liver Cancer Treatment Drug Market Forecast
10.3.6 Australia Liver Cancer Treatment Drug Market Forecast
10.4 Europe Liver Cancer Treatment Drug Forecast by Country (2023-2028)
10.4.1 Germany Liver Cancer Treatment Drug Market Forecast
10.4.2 France Liver Cancer Treatment Drug Market Forecast
10.4.3 UK Liver Cancer Treatment Drug Market Forecast
10.4.4 Italy Liver Cancer Treatment Drug Market Forecast
10.4.5 Russia Liver Cancer Treatment Drug Market Forecast
10.5 Middle East & Africa Liver Cancer Treatment Drug Forecast by Region (2023-2028)
10.5.1 Egypt Liver Cancer Treatment Drug Market Forecast
10.5.2 South Africa Liver Cancer Treatment Drug Market Forecast
10.5.3 Israel Liver Cancer Treatment Drug Market Forecast
10.5.4 Turkey Liver Cancer Treatment Drug Market Forecast
10.5.5 GCC Countries Liver Cancer Treatment Drug Market Forecast
10.6 Global Liver Cancer Treatment Drug Forecast by Type (2023-2028)
10.7 Global Liver Cancer Treatment Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 4SC AG
11.1.1 4SC AG Company Information
11.1.2 4SC AG Liver Cancer Treatment Drug Product Offered
11.1.3 4SC AG Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 4SC AG Main Business Overview
11.1.5 4SC AG Latest Developments
11.2 Alnylam Pharmaceuticals, Inc.
11.2.1 Alnylam Pharmaceuticals, Inc. Company Information
11.2.2 Alnylam Pharmaceuticals, Inc. Liver Cancer Treatment Drug Product Offered
11.2.3 Alnylam Pharmaceuticals, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Alnylam Pharmaceuticals, Inc. Main Business Overview
11.2.5 Alnylam Pharmaceuticals, Inc. Latest Developments
11.3 AVEO Pharmaceuticals, Inc
11.3.1 AVEO Pharmaceuticals, Inc Company Information
11.3.2 AVEO Pharmaceuticals, Inc Liver Cancer Treatment Drug Product Offered
11.3.3 AVEO Pharmaceuticals, Inc Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 AVEO Pharmaceuticals, Inc Main Business Overview
11.3.5 AVEO Pharmaceuticals, Inc Latest Developments
11.4 Bayer AG
11.4.1 Bayer AG Company Information
11.4.2 Bayer AG Liver Cancer Treatment Drug Product Offered
11.4.3 Bayer AG Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bayer AG Main Business Overview
11.4.5 Bayer AG Latest Developments
11.5 Becton, Dickinson and Co.
11.5.1 Becton, Dickinson and Co. Company Information
11.5.2 Becton, Dickinson and Co. Liver Cancer Treatment Drug Product Offered
11.5.3 Becton, Dickinson and Co. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Becton, Dickinson and Co. Main Business Overview
11.5.5 Becton, Dickinson and Co. Latest Developments
11.6 Bristol-Myers Squibb Co.
11.6.1 Bristol-Myers Squibb Co. Company Information
11.6.2 Bristol-Myers Squibb Co. Liver Cancer Treatment Drug Product Offered
11.6.3 Bristol-Myers Squibb Co. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bristol-Myers Squibb Co. Main Business Overview
11.6.5 Bristol-Myers Squibb Co. Latest Developments
11.7 Celsion Corp.
11.7.1 Celsion Corp. Company Information
11.7.2 Celsion Corp. Liver Cancer Treatment Drug Product Offered
11.7.3 Celsion Corp. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Celsion Corp. Main Business Overview
11.7.5 Celsion Corp. Latest Developments
11.8 Dicerna Pharmaceuticals, Inc.
11.8.1 Dicerna Pharmaceuticals, Inc. Company Information
11.8.2 Dicerna Pharmaceuticals, Inc. Liver Cancer Treatment Drug Product Offered
11.8.3 Dicerna Pharmaceuticals, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Dicerna Pharmaceuticals, Inc. Main Business Overview
11.8.5 Dicerna Pharmaceuticals, Inc. Latest Developments
11.9 Eli Lilly and Co.
11.9.1 Eli Lilly and Co. Company Information
11.9.2 Eli Lilly and Co. Liver Cancer Treatment Drug Product Offered
11.9.3 Eli Lilly and Co. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Eli Lilly and Co. Main Business Overview
11.9.5 Eli Lilly and Co. Latest Developments
11.10 Exelixis, Inc.
11.10.1 Exelixis, Inc. Company Information
11.10.2 Exelixis, Inc. Liver Cancer Treatment Drug Product Offered
11.10.3 Exelixis, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Exelixis, Inc. Main Business Overview
11.10.5 Exelixis, Inc. Latest Developments
11.11 F. Hoffmann-La Roche, Ltd.
11.11.1 F. Hoffmann-La Roche, Ltd. Company Information
11.11.2 F. Hoffmann-La Roche, Ltd. Liver Cancer Treatment Drug Product Offered
11.11.3 F. Hoffmann-La Roche, Ltd. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 F. Hoffmann-La Roche, Ltd. Main Business Overview
11.11.5 F. Hoffmann-La Roche, Ltd. Latest Developments
11.12 FibroGen, Inc.
11.12.1 FibroGen, Inc. Company Information
11.12.2 FibroGen, Inc. Liver Cancer Treatment Drug Product Offered
11.12.3 FibroGen, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 FibroGen, Inc. Main Business Overview
11.12.5 FibroGen, Inc. Latest Developments
11.13 General Electric Co.(GE Healthcare)
11.13.1 General Electric Co.(GE Healthcare) Company Information
11.13.2 General Electric Co.(GE Healthcare) Liver Cancer Treatment Drug Product Offered
11.13.3 General Electric Co.(GE Healthcare) Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 General Electric Co.(GE Healthcare) Main Business Overview
11.13.5 General Electric Co.(GE Healthcare) Latest Developments
11.14 Merck & Co., Inc.(ArQule, Inc.)
11.14.1 Merck & Co., Inc.(ArQule, Inc.) Company Information
11.14.2 Merck & Co., Inc.(ArQule, Inc.) Liver Cancer Treatment Drug Product Offered
11.14.3 Merck & Co., Inc.(ArQule, Inc.) Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Merck & Co., Inc.(ArQule, Inc.) Main Business Overview
11.14.5 Merck & Co., Inc.(ArQule, Inc.) Latest Developments
11.15 Novartis International AG
11.15.1 Novartis International AG Company Information
11.15.2 Novartis International AG Liver Cancer Treatment Drug Product Offered
11.15.3 Novartis International AG Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Novartis International AG Main Business Overview
11.15.5 Novartis International AG Latest Developments
11.16 Nymox Corp.
11.16.1 Nymox Corp. Company Information
11.16.2 Nymox Corp. Liver Cancer Treatment Drug Product Offered
11.16.3 Nymox Corp. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Nymox Corp. Main Business Overview
11.16.5 Nymox Corp. Latest Developments
11.17 Pfizer, Inc.
11.17.1 Pfizer, Inc. Company Information
11.17.2 Pfizer, Inc. Liver Cancer Treatment Drug Product Offered
11.17.3 Pfizer, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Pfizer, Inc. Main Business Overview
11.17.5 Pfizer, Inc. Latest Developments
11.18 SMC Laboratories, Inc.
11.18.1 SMC Laboratories, Inc. Company Information
11.18.2 SMC Laboratories, Inc. Liver Cancer Treatment Drug Product Offered
11.18.3 SMC Laboratories, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 SMC Laboratories, Inc. Main Business Overview
11.18.5 SMC Laboratories, Inc. Latest Developments
11.19 Thermo Fisher Scientific, Inc.
11.19.1 Thermo Fisher Scientific, Inc. Company Information
11.19.2 Thermo Fisher Scientific, Inc. Liver Cancer Treatment Drug Product Offered
11.19.3 Thermo Fisher Scientific, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.19.5 Thermo Fisher Scientific, Inc. Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Liver Cancer Treatment Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Targeted Therapy
Table 3. Major Players of Radiation Therapy
Table 4. Major Players of Immunotherapy
Table 5. Major Players of Chemotherapy
Table 6. Major Players of Other
Table 7. Liver Cancer Treatment Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Liver Cancer Treatment Drug Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Liver Cancer Treatment Drug Market Size Market Share by Type (2017-2022)
Table 10. Liver Cancer Treatment Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Liver Cancer Treatment Drug Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Liver Cancer Treatment Drug Market Size Market Share by Application (2017-2022)
Table 13. Global Liver Cancer Treatment Drug Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Liver Cancer Treatment Drug Revenue Market Share by Player (2020-2022)
Table 15. Liver Cancer Treatment Drug Key Players Head office and Products Offered
Table 16. Liver Cancer Treatment Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Liver Cancer Treatment Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Liver Cancer Treatment Drug Market Size Market Share by Regions (2017-2022)
Table 21. Americas Liver Cancer Treatment Drug Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Liver Cancer Treatment Drug Market Size Market Share by Country (2017-2022)
Table 23. Americas Liver Cancer Treatment Drug Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Liver Cancer Treatment Drug Market Size Market Share by Type (2017-2022)
Table 25. Americas Liver Cancer Treatment Drug Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Liver Cancer Treatment Drug Market Size Market Share by Application (2017-2022)
Table 27. APAC Liver Cancer Treatment Drug Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Liver Cancer Treatment Drug Market Size Market Share by Region (2017-2022)
Table 29. APAC Liver Cancer Treatment Drug Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Liver Cancer Treatment Drug Market Size Market Share by Type (2017-2022)
Table 31. APAC Liver Cancer Treatment Drug Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Liver Cancer Treatment Drug Market Size Market Share by Application (2017-2022)
Table 33. Europe Liver Cancer Treatment Drug Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Liver Cancer Treatment Drug Market Size Market Share by Country (2017-2022)
Table 35. Europe Liver Cancer Treatment Drug Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Liver Cancer Treatment Drug Market Size Market Share by Type (2017-2022)
Table 37. Europe Liver Cancer Treatment Drug Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Liver Cancer Treatment Drug Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Liver Cancer Treatment Drug Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Liver Cancer Treatment Drug Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Liver Cancer Treatment Drug Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Liver Cancer Treatment Drug Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Liver Cancer Treatment Drug Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Liver Cancer Treatment Drug Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Liver Cancer Treatment Drug
Table 46. Key Market Challenges & Risks of Liver Cancer Treatment Drug
Table 47. Key Industry Trends of Liver Cancer Treatment Drug
Table 48. Global Liver Cancer Treatment Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Liver Cancer Treatment Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Liver Cancer Treatment Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Liver Cancer Treatment Drug Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Liver Cancer Treatment Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Liver Cancer Treatment Drug Market Size Market Share Forecast by Application (2023-2028)
Table 54. 4SC AG Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 55. 4SC AG Liver Cancer Treatment Drug Product Offered
Table 56. 4SC AG Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. 4SC AG Main Business
Table 58. 4SC AG Latest Developments
Table 59. Alnylam Pharmaceuticals, Inc. Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 60. Alnylam Pharmaceuticals, Inc. Liver Cancer Treatment Drug Product Offered
Table 61. Alnylam Pharmaceuticals, Inc. Main Business
Table 62. Alnylam Pharmaceuticals, Inc. Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Alnylam Pharmaceuticals, Inc. Latest Developments
Table 64. AVEO Pharmaceuticals, Inc Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 65. AVEO Pharmaceuticals, Inc Liver Cancer Treatment Drug Product Offered
Table 66. AVEO Pharmaceuticals, Inc Main Business
Table 67. AVEO Pharmaceuticals, Inc Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. AVEO Pharmaceuticals, Inc Latest Developments
Table 69. Bayer AG Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 70. Bayer AG Liver Cancer Treatment Drug Product Offered
Table 71. Bayer AG Main Business
Table 72. Bayer AG Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Bayer AG Latest Developments
Table 74. Becton, Dickinson and Co. Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 75. Becton, Dickinson and Co. Liver Cancer Treatment Drug Product Offered
Table 76. Becton, Dickinson and Co. Main Business
Table 77. Becton, Dickinson and Co. Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Becton, Dickinson and Co. Latest Developments
Table 79. Bristol-Myers Squibb Co. Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 80. Bristol-Myers Squibb Co. Liver Cancer Treatment Drug Product Offered
Table 81. Bristol-Myers Squibb Co. Main Business
Table 82. Bristol-Myers Squibb Co. Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Bristol-Myers Squibb Co. Latest Developments
Table 84. Celsion Corp. Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 85. Celsion Corp. Liver Cancer Treatment Drug Product Offered
Table 86. Celsion Corp. Main Business
Table 87. Celsion Corp. Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Celsion Corp. Latest Developments
Table 89. Dicerna Pharmaceuticals, Inc. Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 90. Dicerna Pharmaceuticals, Inc. Liver Cancer Treatment Drug Product Offered
Table 91. Dicerna Pharmaceuticals, Inc. Main Business
Table 92. Dicerna Pharmaceuticals, Inc. Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Dicerna Pharmaceuticals, Inc. Latest Developments
Table 94. Eli Lilly and Co. Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 95. Eli Lilly and Co. Liver Cancer Treatment Drug Product Offered
Table 96. Eli Lilly and Co. Main Business
Table 97. Eli Lilly and Co. Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Eli Lilly and Co. Latest Developments
Table 99. Exelixis, Inc. Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 100. Exelixis, Inc. Liver Cancer Treatment Drug Product Offered
Table 101. Exelixis, Inc. Main Business
Table 102. Exelixis, Inc. Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Exelixis, Inc. Latest Developments
Table 104. F. Hoffmann-La Roche, Ltd. Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 105. F. Hoffmann-La Roche, Ltd. Liver Cancer Treatment Drug Product Offered
Table 106. F. Hoffmann-La Roche, Ltd. Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. F. Hoffmann-La Roche, Ltd. Main Business
Table 108. F. Hoffmann-La Roche, Ltd. Latest Developments
Table 109. FibroGen, Inc. Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 110. FibroGen, Inc. Liver Cancer Treatment Drug Product Offered
Table 111. FibroGen, Inc. Main Business
Table 112. FibroGen, Inc. Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 113. FibroGen, Inc. Latest Developments
Table 114. General Electric Co.(GE Healthcare) Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 115. General Electric Co.(GE Healthcare) Liver Cancer Treatment Drug Product Offered
Table 116. General Electric Co.(GE Healthcare) Main Business
Table 117. General Electric Co.(GE Healthcare) Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. General Electric Co.(GE Healthcare) Latest Developments
Table 119. Merck & Co., Inc.(ArQule, Inc.) Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 120. Merck & Co., Inc.(ArQule, Inc.) Liver Cancer Treatment Drug Product Offered
Table 121. Merck & Co., Inc.(ArQule, Inc.) Main Business
Table 122. Merck & Co., Inc.(ArQule, Inc.) Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. Merck & Co., Inc.(ArQule, Inc.) Latest Developments
Table 124. Novartis International AG Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 125. Novartis International AG Liver Cancer Treatment Drug Product Offered
Table 126. Novartis International AG Main Business
Table 127. Novartis International AG Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Novartis International AG Latest Developments
Table 129. Nymox Corp. Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 130. Nymox Corp. Liver Cancer Treatment Drug Product Offered
Table 131. Nymox Corp. Main Business
Table 132. Nymox Corp. Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. Nymox Corp. Latest Developments
Table 134. Pfizer, Inc. Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 135. Pfizer, Inc. Liver Cancer Treatment Drug Product Offered
Table 136. Pfizer, Inc. Main Business
Table 137. Pfizer, Inc. Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Pfizer, Inc. Latest Developments
Table 139. SMC Laboratories, Inc. Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 140. SMC Laboratories, Inc. Liver Cancer Treatment Drug Product Offered
Table 141. SMC Laboratories, Inc. Main Business
Table 142. SMC Laboratories, Inc. Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. SMC Laboratories, Inc. Latest Developments
Table 144. Thermo Fisher Scientific, Inc. Details, Company Type, Liver Cancer Treatment Drug Area Served and Its Competitors
Table 145. Thermo Fisher Scientific, Inc. Liver Cancer Treatment Drug Product Offered
Table 146. Thermo Fisher Scientific, Inc. Main Business
Table 147. Thermo Fisher Scientific, Inc. Liver Cancer Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 148. Thermo Fisher Scientific, Inc. Latest Developments
List of Figures
List of Figures
Figure 1. Liver Cancer Treatment Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Liver Cancer Treatment Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Liver Cancer Treatment Drug Market Size Market Share by Type in 2021
Figure 7. Liver Cancer Treatment Drug in Hepatocellular Carcinoma
Figure 8. Global Liver Cancer Treatment Drug Market: Hepatocellular Carcinoma (2017-2022) & ($ Millions)
Figure 9. Liver Cancer Treatment Drug in Cholangio Carcinoma
Figure 10. Global Liver Cancer Treatment Drug Market: Cholangio Carcinoma (2017-2022) & ($ Millions)
Figure 11. Liver Cancer Treatment Drug in Hepatoblastoma
Figure 12. Global Liver Cancer Treatment Drug Market: Hepatoblastoma (2017-2022) & ($ Millions)
Figure 13. Liver Cancer Treatment Drug in Other
Figure 14. Global Liver Cancer Treatment Drug Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Liver Cancer Treatment Drug Market Size Market Share by Application in 2021
Figure 16. Global Liver Cancer Treatment Drug Revenue Market Share by Player in 2021
Figure 17. Global Liver Cancer Treatment Drug Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Liver Cancer Treatment Drug Market Size 2017-2022 ($ Millions)
Figure 19. APAC Liver Cancer Treatment Drug Market Size 2017-2022 ($ Millions)
Figure 20. Europe Liver Cancer Treatment Drug Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Liver Cancer Treatment Drug Market Size 2017-2022 ($ Millions)
Figure 22. Americas Liver Cancer Treatment Drug Value Market Share by Country in 2021
Figure 23. Americas Liver Cancer Treatment Drug Consumption Market Share by Type in 2021
Figure 24. Americas Liver Cancer Treatment Drug Market Size Market Share by Application in 2021
Figure 25. United States Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Liver Cancer Treatment Drug Market Size Market Share by Region in 2021
Figure 30. APAC Liver Cancer Treatment Drug Market Size Market Share by Application in 2021
Figure 31. China Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Liver Cancer Treatment Drug Market Size Market Share by Country in 2021
Figure 38. Europe Liver Cancer Treatment Drug Market Size Market Share by Type in 2021
Figure 39. Europe Liver Cancer Treatment Drug Market Size Market Share by Application in 2021
Figure 40. Germany Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Liver Cancer Treatment Drug Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Liver Cancer Treatment Drug Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Liver Cancer Treatment Drug Market Size Market Share by Application in 2021
Figure 48. Egypt Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Liver Cancer Treatment Drug Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 54. APAC Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 55. Europe Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 57. United States Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 58. Canada Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 61. China Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 62. Japan Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 63. Korea Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 65. India Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 66. Australia Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 67. Germany Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 68. France Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 69. UK Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 70. Italy Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 71. Russia Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 72. Spain Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 75. Israel Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Liver Cancer Treatment Drug Market Size 2023-2028 ($ Millions)
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)